1. Suppressive effect of microRNA-138 on the proliferation and invasion of osteosarcoma cells via targeting SIRT1
   Zhenchao Yuan et al, 2017 CrossRef
2. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome.
   Agnieszka Rybarczyk et al, 2017, Oncol Rep CrossRef
3. Beyond gene dictation in oral squamous cell carcinoma progression and its therapeutic implications
   Ajay Kumar et al, 2017, Translational Research in Oral Oncology CrossRef
4. MiR-138: A promising therapeutic target for cancer
   Huan-Huan Sha et al, 2017, Tumour Biol. CrossRef
5. “Omics” in oral cancer: New approaches for biomarker discovery
   Vertika Rai et al, 2018, Archives of Oral Biology CrossRef
6. miR-138 inhibits gastric cancer growth by suppressing SOX4
   Lei Pang et al, 2017 CrossRef
7. MicroRNA-138 inhibits cell proliferation in hepatocellular carcinoma by targeting Sirt1
   Jia Luo et al, 2017 CrossRef
8. MicroRNA-138 suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting EZH2 and PI3K/AKT signaling
   Fengzhi Si et al, 2017 CrossRef
9. MicroRNA-138 directly targets TNFAIP8 and acts as a tumor suppressor in osteosarcoma
   Zheng Zhou et al, 2017 CrossRef
10. Long noncoding RNA APTR contributes to osteosarcoma progression through repression of miR-132-3p and upregulation of yes-associated protein 1
    Hongya Guan et al, 2018, J Cell Physiol CrossRef
11. microRNA‐138 Induces Cell Survival and Reduces WNT/β‐Catenin Signaling of Osteoarthritis Chondrocytes Through NEK2
    Weiling Xu et al, 2019, IUBMB Life CrossRef
12. MicroRNA-138 modulates metastasis and EMT in breast cancer cells by targeting vimentin.
    Jun Zhang et al, 2016, Biomed Pharmacother CrossRef
13. null
    N. Bansal et al, 2016 CrossRef
14. SIRT1 in the Development and Treatment of Hepatocellular Carcinoma
    Marius Farcas et al, 2019, Front. Nutr. CrossRef
15. RP11‐284F21.9 promotes oral squamous cell carcinoma development via the miR‐383‐5p/MAL2 axis
    Bingyi Shao et al, 2019, J Oral Pathol Med CrossRef
16. MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1
    Ling Xiao et al, 2016, Oncotarget CrossRef
17. Fascin promotes migration and invasion and is a prognostic marker for oral squamous cell carcinoma.
    Priscila Campioni Rodrigues et al, 2017, Oncotarget CrossRef
18. Noncoding RNAs in oral premalignant disorders and oral squamous cell carcinoma
    Fei Huang et al, 2020, Cell Oncol. CrossRef
19. MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression
    Yong-Mei Zhou et al, 2020, CBM CrossRef
20. MicroRNA-138-5p Suppresses Non-small Cell Lung Cancer Cells by Targeting PD-L1/PD-1 to Regulate Tumor Microenvironment
    Nannan Song et al, 2020, Front. Cell Dev. Biol. CrossRef
21. MicroRNA‑138 inhibits tumor growth and enhances chemosensitivity in human cervical cancer by targeting H2AX
    Min Yuan et al, 2019, Exp Ther Med CrossRef
22. Long non-coding RNA NEAT1 promotes migration and invasion of oral squamous cell carcinoma cells by sponging microRNA-365.
    Xiaohua Liu et al, 2018, Exp Ther Med CrossRef
23. MicroRNA‑138 targets SP1 to inhibit the proliferation, migration and invasion of hepatocellular carcinoma cells
    Chongzhong Liu et al, 2017, Oncol Lett CrossRef
24. Long non-coding RNA H1 promotes cell proliferation and invasion by acting as a ceRNA of miR‑138 and releasing EZH2 in oral squamous cell carcinoma
    Yonglong Hong et al, 2018, Int J Oncol CrossRef
25. MicroRNA‑138 suppresses cell proliferation and invasion of renal cell carcinoma by directly targeting SOX9
    Bo Hu et al, 2017, Oncol Lett CrossRef
26. Prospective applications of microRNAs in oral cancer: A review (Review)
    Chuan Fang et al, 2019, Oncol Lett CrossRef
27. MicroRNA profile in the squamous cell carcinoma: prognostic and diagnostic roles
    Soudeh Ghafouri-Fard et al, 2020, Heliyon CrossRef
28. Circ-HIPK3 regulates YAP1 expression by sponging miR-381-3p to promote oral squamous cell carcinoma development
    Lei Bi et al, 2021, J Biosci CrossRef
29. MicroRNAs as Modulators of Oral Tumorigenesis—A Focused Review
    Kumar Rishabh et al, 2021, IJMS CrossRef
30. Upregulation of miR-138 Increases Sensitivity to Cisplatin in Hepatocellular Carcinoma by Regulating EZH2
    Taohui Zeng et al, 2021, BioMed Research International CrossRef
31. miR-138-5p Inhibits the Growth and Invasion of Glioma Cells by Regulating WEE1
    Jianwu Gong et al, 2022, Analytical Cellular Pathology CrossRef
32. MicroRNA-138 and its targets: A therapeutic molecule for oral squamous cell carcinoma
    Sushmaa Chandralekha Selvakumar et al, 2022, Oral Oncology CrossRef
33. microRNAs in oral cancer: Moving from bench to bed as next generation medicine.
    Wendy D'Souza et al, 2020, Oral Oncol CrossRef
34. Aberrant expression of miR-138 as a novel diagnostic biomarker in systemic sclerosis
    Paria Bayati et al, 2022, Biomark�Insights CrossRef
35. Brucea javanica oil inhibits tongue squamous cell invasion and metastasis by regulating miR-138-EZH2 pathway
    Lin Jiang et al, 2023, Journal of Stomatology, Oral and Maxillofacial Surgery CrossRef
36. Unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of oral cancer
    Ahmed S. Doghish et al, 2023, Pathology - Research and Practice CrossRef